Oncotarget

Research Papers:

Upregulation of long non-coding RNA CCAT1 promotes proliferation and metastasis of esophageal squamous cell carcinoma cells by regulating the miR-543/KRAS axis

Yu Mao _, Lixin Dong, Jia Liu, Liang Li, Le Wang, Yan Zhou, Yanqiu Zhang, Sen Yang, Liyan Cao, Chao Wang and Zhanzhao Fu

PDF  |  HTML  |  Supplementary Files  |  How to cite

DOI pending

Metrics: PDF 302 views  |   HTML 453 views  |   ?  


Abstract

Yu Mao1, Lixin Dong1, Jia Liu2, Liang Li3, Le Wang4, Yan Zhou5, Yanqiu Zhang1, Sen Yang1, Liyan Cao1, Chao Wang6 and Zhanzhao Fu1

1Department of Oncology, The First Hospital of Qinhuangdao, Qinhuangdao, Hebei, China

2Institute of Basic Medical Sciences, Qilu Hospital, Shandong University, Jinan, China

3Department of Ultrasound, Beijing Anzhen Hospital, Capital Medical University, Beijing, China

4Department of Neurosurgery, Tianjin Medical University General Hospital, Tianjin Neurological Institute and Laboratory of Neuro-Oncology, Tianjin, China

5Department of Oncology Radiation, Tianjin Medical University General Hospital, Tianjin, China

6Department of Thoracic Surgery, The First Hospital of Qinhuangdao, Qinhuangdao, China

Correspondence to:

Zhanzhao Fu, email: [email protected]

Keywords: ESCC; progression; long non-coding RNA; CCAT1

Received: February 27, 2017     Accepted: August 23, 2017     Published: January 02, 2018

ABSTRACT

Dysregulation of long non-coding RNA (lncRNAs) plays vital roles in tumorigenesis and cancer progression. Previous studies have identified the role of the lncRNA CCAT1 as an oncogene in several cancer types, and ectopic expression of CCAT1 predicts a poor prognosis. This study sought to determine the underlying mechanism for this observation in esophageal squamous cell carcinoma (ESCC). We found that CCAT1 was significantly upregulated in human ESCC tumor tissues and cell lines. LncRNA CCAT1 overexpression enhanced cell proliferation, migration, and invasion in vitro and in vivo. Our bioinformatics analysis and RNA immunoprecipitation assays combined with dual-luciferase assays revealed that CCAT1 functions as a microRNA (miRNA) sponge for miR-543. Increased CCAT1 antagonized the functions of miRNA-543 and led to de-repression of its downstream target, KRAS, which is a core oncogene that facilitates ESCC progression. Our findings suggest that CCAT1 increases KRAS expression by sponging miR-543 and thus promotes ESCC progression. This study sheds light on the potential role of lncRNAs as a novel prognostic biomarker and provides a new therapeutic target for ESCC.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 23864